Diagnosis and Treatment of Psoriasis
Diagnosis and Treatment of Psoriasis
Diagnosis and Treatment of Psoriasis
Pembimbing :
dr. Siti Nur Rahmah Sp.KK
• an de Kerkhof PC., Nestle FO. Psoriasis. In: Bolognia JL, Schaffer J V, Cerroni L, editors. Dermatology. 4th ed. USA: Elsevier; 2018. p. 13860.
V
• Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):26472.
Definition
Psoriasis is an inflammatory chronic disease of
skin. The lesions can be erythematous plaques
with a circumscriptive white layered scales. Can
be localized, such as on the elbows, knees, scalp,
and other extensor areas.
Jacoeb TNA. Psoriasis. In: Menaloi SL, editor. Ilmu Penyakit Kulit dan Kelamin. 7th ed. Jakarta: Badan Penerbit FKUI; 2016. p. 213-22.
EPIDEMIOLOGY
• Cases of psoriasis are often found universally in parts of the world and
reach 125 million human.
• Prevalence of man and women is same.
- Children : 0 – 2,1%
- Adult : 0,98 – 8%
• In Indonesia, prevalence of psoriasis reach 1-3 percent from population of
Indonesia.
• Psoriasis vulgaris is the most common form of psoriasis. found in about
90% of patients.
• Jacoeb TNA. Psoriasis. In: Menaloi SL, editor. Ilmu Penyakit Kulit dan Kelamin. 7th ed. Jakarta: Badan Penerbit FKUI; 2016. p. 213-22.
• World Health Organization. 2016. Global Report on Psoriasis. Switzerland, h:7- 10.
Etiopathogenesis of Psoriasis
• Psoriasis → Sustained inflammation →
uncontrolled keratinocyte proliferation and
dysfunctional differentiation.
• Psoriasis has a genetic component that is
supported by patterns of familial aggregation.
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International journal of molecular sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Etiopathogenesis of Psoriasis
The pathogenesis of psoriasis can be conceptualized
into:
• initiation phase possibly triggered → by trauma
(Koebner phenomenon), infection, or drugs.
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International journal of molecular sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Etiopathogenesis of Psoriasis
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International journal of molecular sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Clinical Manifestation
Before After
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
• Koebner phenomenon is traumatic
induction on psoriasis non lesion skin
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
PSORIASIS TYPES
1) Psoriasis Vulgaris
2) Psoriasis Inversa
3) Psoriasis Gutata
4) Psoriasis Pustulosa
5) Erythroderma
6) Nail Psoriasis
7) Psoriasis Arthritis
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Psoriasis Vulgaris
• Psoriasis vulgaris is the most
common form of psoriasis
• The Primary lesion is Red, scaly
systematically distributed plaques
• It is symmetrically distributed
plaques to the extensor aspects of
the extremities; particularly the
elbows and knees, along with
scalp, lower lumbosacral,
buttocks, and genital involvement
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Psoriasis Gutata
• It is characterized by eruption of
small (0.5–1.5 cm in diameter)
papules over the upper trunk and
proximal extremities
• It typically manifests at an early age
• It has the strongest association to
HLA-Cw6
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Psoriasis Inversa
• The lesions show a glossy sharply
demarcated erythema
• Psoriasis lesions may be localized in
the major skin folds, such as the
axillae, the genitocrural region, and
the neck
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Psoriasis postulosa
• The attacks are characterized by fever
that lasts several days and a sudden
generalized eruption of sterile
pustules 2 to 3 mm in diameter
• The pustules are disseminated over
the trunk and extremities, including
the nail beds, palms, and soles.
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Erythroderma
• Erythema is the most prominent
feature with superficial scaling
• Affects all body sites, including the
face, hands, feet, nails, trunk, and
extremities
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Nail Psoriasis
• Pits range from 0.5 to 2.0 mm
in size and can be single or
multiple
• Other forms are yellowish
dish discoloration or oil spot ,
onycholysis , hyperkeratosis
subungual
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Psoriasis Arthritis
• Most commonly a
seronegative oligoarthritis
• Skin lesions include scaly,
erythematous plaques; guttate
lesions; lakes of pus; and
erythroderma
• Psoriasis may occur in
hidden sites, such as the
scalp, perineum, intergluteal
cleft, and umbilicus
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Algorithm diagnosis and treatment of psoariasis
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Diagnose
Clinical Manifestation Onset of the Disease
( Symptoms and Signs ) ( When did it start ? )
Physical Examination
( Symetrical Lesions , Its
distribution , Circumscribed
lesion , Thick white scally
layers )
Gudjonsson,
Gudjonsson, J.E.
J.E. dan
dan J.T.
J.T. Elder.
Elder. 2019.
2019. Psoriasis.
Psoriasis. Dalam:
Dalam: Kang,
Kang, S.,
S., Amagai,
Amagai, M.,
M., Bruckner,
Bruckner, A.L.,
A.L., Enk,
Enk, A.H.,
A.H., Margolis,
Margolis, D.J.,
D.J., McMichael,
McMichael, A.J.,
A.J., Orringer,
Orringer, J.S.
J.S. (editor).
(editor). Fitzpatrick’s
Fitzpatrick’s
Laboratory Findings
• Histopathology : hyperkeratosis, parakeratosis,
acanthosis
Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45(3):264–72.
Differential Diagnosis
Seborrheic dermatitis
Secondary syphilis
Tinea corporis
Pityriasis Rosea
• Tucker D, Masood S. 2021. Seborrheic Dermatitis. Aga Khan University Hospital karachi. [Accessed 28 des 2021]Seborrheic Dermatitis - StatPearls - NCBI Bookshelf (nih.gov)
• Rukin N. 2018. Sexually Transmitted Infection. [Accessed 28 des 2021] Sexually transmitted infections | Urology News
• Yee G, Ahmad M. 2021. Tinea Corporis. King Abdullah Medical City. [Accessed 28 des 2021]Tinea Corporis - StatPearls - NCBI Bookshelf (nih.gov)
• Gudjonsson, J.E. dan J.T. Elder. 2019. Pityriasis Rosea. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
Treatment
Gudjonsson, J.E. dan J.T. Elder. 2019. Psoriasis. Dalam: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringer, J.S. (editor). Fitzpatrick’s
• Psoriatic patients are frequently categorized
into three groups: mild, moderate and severe
psoriasis.
• Depending on the clinical severity of the
lesions (Psoriasis Area and Severity Index), the
percentage of affected body surface area (Body
Surface Area), and patient quality of life
(Dermatology Life QuaIity Index).
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International journal of molecular sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Psoriasis Area and Severity Index
Body Surface Area
&
Dermatology Life QuaIity Index
Topical therapy
• Topical application of corticosteroids is generally
suitable for limited plaques.
• Liquor Carbonis Detergens, can be compounded into
agents for topical use.
• Salicylic acid is used as a keratolytic agent It can
promote the absorption of other topical agents.
• Treatment with the vitamin D analog calcipotriene
• Phototherapy for widespread psoriasis.
William D james , Timothy G Berger , Dirk M Elston , Andrew’s Disease of the skin Clinical Dermatology 11th ed . Elsevier ;2006 . ISBN 978-0-8089-2417-3
Systemic treatment
• Methotrexate → This folic acid antagonist
remains the standard.
– Indications → psoriatic erythroderma, psoriatic
arthritis, acute pustular psoriasis, or widespread
body surface involvement.
– The patient has no history of liver or kidney
disease.
– Oral doses 2,5 – 5 mg (12 h apart) + Oral folic acid
doses of 1–4 mg/day are used.
William D james , Timothy G Berger , Dirk M Elston , Andrew’s Disease of the skin Clinical Dermatology 11th ed . Elsevier ;2006 . ISBN 978-0-8089-2417-3
Systemic treatment
• Cyclosporine → The therapeutic benefit of
cyclosporine in psoriatic disease may be
related to down modulation of pro
inflammatory epidermal cytokines.
– Doses of 2–5 mg/kg/day generally produce rapid
clearing of psoriasis.
William D james , Timothy G Berger , Dirk M Elston , Andrew’s Disease of the skin Clinical Dermatology 11th ed . Elsevier ;2006 . ISBN 978-0-8089-2417-3
Biologic agents
• Target specific inflammatory pathways and are
administered SC or IV on different weekly schedules.
• Biologics presently target two pathways crucial in the
development and chronicity of the psoriatic plaque:
the IL-23/Th17 axis and TNF-α-signaling.
– TNF-α inhibitors → etanercept, infliximab, adalimumab.
– IL-23 → ustekinumab
– IL-17 → Secukinumab
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International journal of molecular sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
• Mild to moderate psoriasis can be treated
topically with a combination of
glucocorticoids, vitamin D analogues, and
phototherapy.
• Moderate to severe psoriasis often requires
systemic treatment. The presence of
comorbidities such as psoriasis arthritis is also
highly relevant in treatment selection.
Rendon, A., & Schäkel, K. (2019). Psoriasis Pathogenesis and Treatment. International journal of molecular sciences, 20(6), 1475. https://doi.org/10.3390/ijms20061475
Prevention of Psoriasis
• Avoid the stress
• Avoid the smoking
• Avoid the alchol
• Avoid the drugs lead the psoriasis
• Organize Body Mass Index
• Rousset L, Halioua B. Stress and psoriasis. Int J Dermatol. 2018 Oct;57(10):1165-1172. doi: 10.1111/ijd.14032. Epub 2018 May 4. PMID: 29729012.
• Pezzolo E, Naldi L. The relationship between smoking, psoriasis and psoriatic arthritis. Expert Rev Clin Immunol. 2019 Jan;15(1):41-48. doi:10.1080/1744666X.2019.1543591. Epub 2018 Nov 6. PMID:
30380949
• Svanström C, Lonne-Rahm SB, Nordlind K. Psoriasis and alcohol. Psoriasis (Auckl). 2019 Aug 21;9:75-79. doi: 10.2147/PTT.S164104. PMID: 31687362; PMCID: PMC6709030.
• Roszkiewicz M, Dopytalska K, Szymańska E, Jakimiuk A, Walecka I. Environmental risk factors and epigenetic alternations in psoriasis. Ann Agric Environ Med. 2020 Sep 11;27(3):335-342. doi:
10.26444/aaem/112107. Epub 2019 Nov 12. PMID: 32955211.
• Grželj J, Sollner Dolenc M. The role of xenobiotics in triggering psoriasis. Arch Toxicol. 2020 Dec;94(12):3959-3982. doi: 10.1007/s00204-020-02870-8. Epub 2020 Aug 24. PMID: 32833044.
Prognose
• The prognose of this disease is bonam if the
patient get an effective therapy.
• But sometimes psoriasis can be chronic
recurrent.
– Ad vitam : Dubia ad Bonam
– Ad functionam : Dubia ad Bonam
– Ad sanationam : Dubia ad Malam
• Van de Kerkhof PC., Nestle FO. Psoriasis. In: Bolognia JL, Schaffer J V, Cerroni L, editors. Dermatology. 4th ed. USA: Elsevier; 2018. p. 138-60.
• Widaty S, Soebono H, Nilasari H, dkk. Panduan Praktik Klinis bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta: Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia; 2017. h.230-41
Conclution
THANK YOU
“ PSORIASIS is not Contagious but, Awareness is”
#STAYSAFE
Makassar, Indonesia